Ethypharm is ready to make deals happen

Our Corporate Development activities are fully focused on the reinforcement of our position along three axes:

• Commercial presence in Europe: any type of deal (assets and in-licensing, or company acquisition) which will reinforce our position in our existing markets or allow us to expand our presence in Europe will be given consideration.
• Central Nervous System and Hospital Injectables: we are looking for already marketed or late-stage R&D branded prescription medicines to complement our existing portfolio of products in these two major areas.
• Rare diseases in China: our longstanding affiliate, which has full value-chain capabilities and deep knowledge of the local fast-changing environment, is a partner of choice for international companies wishing to register and commercialise their rare disease medicines in China.

Ethypharm’s dedicated Corporate Development team is composed of professional individuals who have a proven deal-making track record. Acting both as scouts and deal process managers, each member of the team can rely on the full support of our internal experts to conduct an initial assessment and due diligence in a timely manner.

Our robust internal process also guarantees that our shareholders are fully aligned from the start and ready to support the financing of the deal if needed.